These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 38907188)
1. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy. Fan Y; Wang Y; Xiao H; Sun H BMC Nephrol; 2024 Jun; 25(1):203. PubMed ID: 38907188 [TBL] [Abstract][Full Text] [Related]
2. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. He JW; Zhou XJ; Lv JC; Zhang H Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226 [TBL] [Abstract][Full Text] [Related]
3. Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue. Barratt J Nephrology (Carlton); 2024 Sep; 29 Suppl 2():34-36. PubMed ID: 39327765 [TBL] [Abstract][Full Text] [Related]
4. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients. Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215 [TBL] [Abstract][Full Text] [Related]
5. The Gut-Renal Connection in IgA Nephropathy. Coppo R Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy. Tang Y; Xiao Y; He H; Zhu Y; Sun W; Hu P; Xu X; Liu Z; Yan Z; Wei M Kidney Blood Press Res; 2023; 48(1):261-276. PubMed ID: 36878203 [TBL] [Abstract][Full Text] [Related]
7. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy. Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697 [TBL] [Abstract][Full Text] [Related]
9. Role of gut microbiome in ankylosing spondylitis: an analysis of studies in literature. Xu YY; Tan X; He YT; Zhou YY; He XH; Huang RY Discov Med; 2016 Dec; 22(123):361-370. PubMed ID: 28147218 [TBL] [Abstract][Full Text] [Related]
10. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859 [TBL] [Abstract][Full Text] [Related]
11. Spinal cord injury and the human microbiome: beyond the brain-gut axis. Wallace DJ; Sayre NL; Patterson TT; Nicholson SE; Hilton D; Grandhi R Neurosurg Focus; 2019 Mar; 46(3):E11. PubMed ID: 30835680 [TBL] [Abstract][Full Text] [Related]
12. Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection. Onabajo OO; Mattapallil JJ Front Immunol; 2021; 12():657679. PubMed ID: 33815419 [TBL] [Abstract][Full Text] [Related]
13. Role of gut-kidney axis in renal diseases and IgA nephropathy. Monteiro RC; Berthelot L Curr Opin Gastroenterol; 2021 Nov; 37(6):565-571. PubMed ID: 34482323 [TBL] [Abstract][Full Text] [Related]
14. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease. Chi M; Ma K; Wang J; Ding Z; Li Y; Zhu S; Liang X; Zhang Q; Song L; Liu C J Immunol Res; 2021; 2021():5516035. PubMed ID: 34095319 [TBL] [Abstract][Full Text] [Related]
15. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls. Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657 [TBL] [Abstract][Full Text] [Related]
16. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy. Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice. Chemouny JM; Gleeson PJ; Abbad L; Lauriero G; Boedec E; Le Roux K; Monot C; Bredel M; Bex-Coudrat J; Sannier A; Daugas E; Vrtovsnik F; Gesualdo L; Leclerc M; Berthelot L; Ben Mkaddem S; Lepage P; Monteiro RC Nephrol Dial Transplant; 2019 Jul; 34(7):1135-1144. PubMed ID: 30462346 [TBL] [Abstract][Full Text] [Related]
18. The microbiome and IgA nephropathy. Haniuda K; Gommerman JL; Reich HN Semin Immunopathol; 2021 Oct; 43(5):649-656. PubMed ID: 34664087 [TBL] [Abstract][Full Text] [Related]
19. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. Shah A; Macdonald GA; Morrison M; Holtmann G Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997 [TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy? Monteiro RC; Rafeh D; Gleeson PJ Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]